vs
Side-by-side financial comparison of Aligos Therapeutics, Inc. (ALGS) and Quantum Computing Inc. (QUBT). Click either name above to swap in a different company.
Quantum Computing Inc. is the larger business by last-quarter revenue ($198.0K vs $169.0K, roughly 1.2× Aligos Therapeutics, Inc.). On growth, Quantum Computing Inc. posted the faster year-over-year revenue change (219.4% vs -72.1%). Over the past eight quarters, Quantum Computing Inc.'s revenue compounded faster (99.0% CAGR vs -50.7%).
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel targeted therapies for prevalent liver diseases and viral infections. Its core pipeline includes candidates for chronic hepatitis B, non-alcoholic steatohepatitis, and other liver-related disorders, advancing R&D to serve unmet global patient needs.
Rigetti Computing, Inc. is a Berkeley, California-based developer of superconducting quantum integrated circuits used for quantum computers. Rigetti also develops a cloud platform called Forest that enables programmers to write quantum algorithms.
ALGS vs QUBT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $169.0K | $198.0K |
| Net Profit | — | $-1.6M |
| Gross Margin | — | -49.5% |
| Operating Margin | — | -11220.2% |
| Net Margin | — | -785.9% |
| Revenue YoY | -72.1% | 219.4% |
| Net Profit YoY | 75.8% | 97.0% |
| EPS (diluted) | — | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $169.0K | $198.0K | ||
| Q3 25 | $741.0K | $384.0K | ||
| Q2 25 | $965.0K | $61.0K | ||
| Q1 25 | $311.0K | — | ||
| Q4 24 | $606.0K | $62.0K | ||
| Q3 24 | $1.3M | $101.0K | ||
| Q2 24 | $1.1M | $183.0K | ||
| Q1 24 | $694.0K | — |
| Q4 25 | — | $-1.6M | ||
| Q3 25 | $-31.5M | $2.4M | ||
| Q2 25 | $-15.9M | $-36.5M | ||
| Q1 25 | $43.1M | — | ||
| Q4 24 | $-82.2M | $-51.2M | ||
| Q3 24 | $-19.3M | $-5.7M | ||
| Q2 24 | $5.1M | $-5.2M | ||
| Q1 24 | $-34.9M | — |
| Q4 25 | — | -49.5% | ||
| Q3 25 | — | 32.8% | ||
| Q2 25 | — | 42.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 54.8% | ||
| Q3 24 | — | 8.9% | ||
| Q2 24 | — | 31.7% | ||
| Q1 24 | — | — |
| Q4 25 | — | -11220.2% | ||
| Q3 25 | -3827.4% | -2709.4% | ||
| Q2 25 | -1924.0% | -16673.8% | ||
| Q1 25 | -6187.5% | — | ||
| Q4 24 | -3393.2% | -14375.8% | ||
| Q3 24 | -1610.5% | -5384.2% | ||
| Q2 24 | -2489.5% | -2878.1% | ||
| Q1 24 | -3176.7% | — |
| Q4 25 | — | -785.9% | ||
| Q3 25 | -4256.0% | 620.3% | ||
| Q2 25 | -1643.8% | -59806.6% | ||
| Q1 25 | 13854.7% | — | ||
| Q4 24 | -13556.1% | -82640.3% | ||
| Q3 24 | -1540.7% | -5618.8% | ||
| Q2 24 | 477.0% | -2838.3% | ||
| Q1 24 | -5023.5% | — |
| Q4 25 | — | $0.03 | ||
| Q3 25 | $-3.04 | $0.01 | ||
| Q2 25 | $-1.53 | $-0.26 | ||
| Q1 25 | $-2.11 | — | ||
| Q4 24 | $-13.10 | $-0.53 | ||
| Q3 24 | $-3.07 | $-0.06 | ||
| Q2 24 | $0.81 | $-0.06 | ||
| Q1 24 | $-5.58 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $77.8M | $1.1B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $53.5M | $1.6B |
| Total Assets | $88.5M | $1.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $77.8M | $1.1B | ||
| Q3 25 | $99.1M | $555.6M | ||
| Q2 25 | $122.9M | $348.8M | ||
| Q1 25 | $137.9M | — | ||
| Q4 24 | $56.9M | $78.9M | ||
| Q3 24 | $74.9M | $3.1M | ||
| Q2 24 | $94.5M | $2.5M | ||
| Q1 24 | $112.7M | — |
| Q4 25 | $53.5M | $1.6B | ||
| Q3 25 | $71.8M | $877.9M | ||
| Q2 25 | $101.9M | $396.0M | ||
| Q1 25 | $116.4M | — | ||
| Q4 24 | $-29.0M | $107.3M | ||
| Q3 24 | $50.1M | $60.4M | ||
| Q2 24 | $67.2M | $65.5M | ||
| Q1 24 | $59.8M | — |
| Q4 25 | $88.5M | $1.6B | ||
| Q3 25 | $109.8M | $898.2M | ||
| Q2 25 | $134.7M | $426.1M | ||
| Q1 25 | $150.7M | — | ||
| Q4 24 | $70.1M | $153.6M | ||
| Q3 24 | $88.4M | $76.8M | ||
| Q2 24 | $108.8M | $76.0M | ||
| Q1 24 | $127.9M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-82.5M | $-11.0M |
| Free Cash FlowOCF − Capex | — | $-12.2M |
| FCF MarginFCF / Revenue | — | -6147.5% |
| Capex IntensityCapex / Revenue | — | 583.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-37.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-82.5M | $-11.0M | ||
| Q3 25 | $-24.3M | $-8.7M | ||
| Q2 25 | $-15.5M | $-6.1M | ||
| Q1 25 | $-20.9M | — | ||
| Q4 24 | $-18.4M | $-3.8M | ||
| Q3 24 | $-20.1M | $-4.6M | ||
| Q2 24 | $-19.5M | $-4.0M | ||
| Q1 24 | $-22.7M | — |
| Q4 25 | — | $-12.2M | ||
| Q3 25 | — | $-11.5M | ||
| Q2 25 | — | $-7.1M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-6.6M | ||
| Q3 24 | — | $-5.1M | ||
| Q2 24 | — | $-5.1M | ||
| Q1 24 | — | — |
| Q4 25 | — | -6147.5% | ||
| Q3 25 | — | -3000.3% | ||
| Q2 25 | — | -11683.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -10709.7% | ||
| Q3 24 | — | -5040.6% | ||
| Q2 24 | — | -2782.0% | ||
| Q1 24 | — | — |
| Q4 25 | — | 583.8% | ||
| Q3 25 | — | 723.2% | ||
| Q2 25 | — | 1678.7% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4622.6% | ||
| Q3 24 | — | 508.9% | ||
| Q2 24 | — | 588.5% | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -3.67× | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.49× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -3.85× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
